|
GB9720465D0
(en)
|
1997-09-25 |
1997-11-26 |
Oxford Biomedica Ltd |
Dual-virus vectors
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
EP1224313A1
(en)
|
1999-10-07 |
2002-07-24 |
University of Iowa Research Foundation |
Adeno-associated viruses and uses thereof
|
|
US6544786B1
(en)
|
1999-10-15 |
2003-04-08 |
University Of Pittsburgh Of The Commonwealth Of Higher Education |
Method and vector for producing and transferring trans-spliced peptides
|
|
AU4445701A
(en)
|
2000-03-24 |
2001-10-03 |
Centre National De La Recherche Scientifique-Cnrs |
Multiple human and mouse otoferlin isoforms
|
|
US20040072154A1
(en)
|
2000-12-22 |
2004-04-15 |
Morris David W. |
Novel compositions and methods for cancer
|
|
CA2442670A1
(en)
*
|
2001-04-13 |
2002-10-24 |
The Trustees Of The University Of Pennsylvania |
Method of treating or retarding the development of blindness
|
|
JP2003088388A
(ja)
|
2001-09-14 |
2003-03-25 |
Herikkusu Kenkyusho:Kk |
新規な全長ｃＤＮＡ
|
|
EP2434020B1
(en)
|
2004-01-22 |
2014-11-05 |
Dnavec Research Inc. |
Method of producing Paramyxoviridae viral vectors using a hybrid promoter comprising a cytomegalovirus enhancer and a chicken beta-actin promoter
|
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
|
US8298818B2
(en)
|
2006-04-28 |
2012-10-30 |
University Of Florida Research Foundation, Inc. |
Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
WO2008088895A2
(en)
|
2007-01-18 |
2008-07-24 |
University Of Missouri-Columbia |
Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
|
|
FR2919305B1
(fr)
|
2007-07-26 |
2009-09-18 |
Genethon Ass Loi De 1901 |
Vecteurs viraux adeno-associes pour l'expression de la dysferline.
|
|
EP2254572B1
(en)
|
2008-02-07 |
2013-10-16 |
Massachusetts Eye & Ear Infirmary |
Compounds that enhance atoh-1 expression
|
|
WO2009108274A2
(en)
*
|
2008-02-26 |
2009-09-03 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for adeno-associated virus (aav) with hi loop mutations
|
|
US8236557B2
(en)
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
WO2010062905A2
(en)
|
2008-11-26 |
2010-06-03 |
The Regents Of The University Of California |
Lateral ventricle cell compositions and use for treating neural degenerative diseases
|
|
HUE041571T2
(hu)
|
2010-04-23 |
2019-05-28 |
Univ Florida |
RAAV-guanilát-cikláz-készítmények és ejárások 1-es típusú Leber-féle veleszületett vakság (LCA1) kezelésére
|
|
WO2013075008A1
(en)
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
BR112014020325A2
(pt)
*
|
2012-02-17 |
2017-08-08 |
Childrens Hospital Philadelphia |
composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
JP6342886B2
(ja)
|
2012-04-18 |
2018-06-13 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ |
Ａａｖカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
|
|
CA2884309A1
(en)
|
2012-09-07 |
2014-03-13 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity
|
|
CN105209619B
(zh)
|
2013-03-11 |
2018-10-12 |
泰莱托恩基金会 |
miR-204和miR-211及其用途
|
|
DK2986635T3
(en)
*
|
2013-04-18 |
2019-01-28 |
Fond Telethon |
EFFECTIVE DELIVERY OF BIG GENES THROUGH DUAL-AAV VECTORS
|
|
KR102298579B1
(ko)
|
2013-05-21 |
2021-09-07 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도
|
|
US11000597B2
(en)
|
2015-01-21 |
2021-05-11 |
University Of Florida Research Foundation, Incorporated |
Engineered receptor/ligand system for delivery of therapeutic agents
|
|
US10751385B2
(en)
*
|
2015-02-20 |
2020-08-25 |
Institut Pasteur |
Prevention and/or treatment of hearing loss or impairment
|
|
CA2979120A1
(en)
|
2015-03-03 |
2016-09-09 |
Fondazione Telethon |
Multiple aav vector system for expressing genes over 5 kilobases, comprising at least one degradation signal and uses thereof
|
|
AU2016324317A1
(en)
|
2015-09-17 |
2018-03-08 |
Coda Biotherapeutics, Inc. |
Compositions and methods for treating neurological disorders
|
|
CA3007476A1
(en)
*
|
2015-12-11 |
2017-06-15 |
Massachusetts Eye And Ear Infirmary |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
EP3393522B1
(en)
|
2015-12-22 |
2021-07-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Improved hybrid dual recombinant aav vector systems for gene therapy
|
|
AU2017286623A1
(en)
|
2016-06-15 |
2018-12-20 |
Oxford University Innovation Limited |
Dual overlapping adeno-associated viral vector system for expressing ABC4A
|
|
WO2018039375A1
(en)
|
2016-08-23 |
2018-03-01 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
CN111698975A
(zh)
|
2017-02-06 |
2020-09-22 |
儿童医疗中心有限公司 |
将核酸递送至耳蜗和前庭细胞的材料和方法
|
|
MA47820A
(fr)
|
2017-03-10 |
2020-01-15 |
Genethon |
Traitement de la glycogénose de type iii
|
|
US12359221B2
(en)
*
|
2017-05-05 |
2025-07-15 |
The Regents Of The University Of California |
Compositions and methods for expressing otoferlin
|
|
DE102018103924A1
(de)
|
2018-02-21 |
2019-08-22 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Gentherapeutische Behandlung von Schwerhörigkeit
|
|
IL325122A
(en)
*
|
2018-02-22 |
2026-02-01 |
Akouos Inc |
Compositions and methods for treating non-age-related hearing impairment in humans
|
|
US20190345516A1
(en)
*
|
2018-03-12 |
2019-11-14 |
Musc Foundation For Research Development |
Methods for treating eye disease
|
|
CA3094828A1
(en)
|
2018-03-23 |
2019-09-26 |
Massachusetts Eye And Ear Infirmary |
Crispr/cas9-mediated exon-skipping approach for ush2a-associated usher syndrome
|
|
CN112703016B
(zh)
*
|
2018-04-27 |
2024-11-22 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
US11660353B2
(en)
*
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
WO2020093018A1
(en)
|
2018-11-01 |
2020-05-07 |
University Of Florida Research Foundation, Incorporated |
A codon optimized otoferlin aav dual vector gene therapy
|
|
CN113853437A
(zh)
|
2018-11-07 |
2021-12-28 |
阿库斯股份有限公司 |
腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途
|
|
CA3125770A1
(en)
|
2019-01-18 |
2020-07-23 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
CN113924109A
(zh)
|
2019-01-18 |
2022-01-11 |
巴斯德研究所 |
Aav介导的基因疗法恢复耳畸蛋白基因
|
|
WO2020163761A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
TWI896570B
(zh)
|
2019-10-30 |
2025-09-11 |
美商迪賽博治療公司 |
使用耳畸蛋白雙載體系統治療感覺神經性聽力損失之組合物及方法
|
|
CA3168055A1
(en)
|
2020-02-21 |
2021-08-26 |
Emmanuel John Simons |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
IL295741A
(en)
|
2020-04-01 |
2022-10-01 |
Univ Florida |
Dual aav-myo7a vectors with improved safety for the treatment of ush1b
|
|
KR20240004253A
(ko)
|
2021-02-19 |
2024-01-11 |
데시벨 테라퓨틱스, 인크. |
오토펄린 듀얼 벡터 시스템을 사용한 감각신경성 난청을 치료하기 위한 방법
|
|
CN121002049A
(zh)
|
2023-02-17 |
2025-11-21 |
分贝治疗公司 |
用于施用耳畸蛋白双载体系统的方法和组合物
|